W6Q2 Three programs that provide care for the dying

/in /by

List three programs that provide care for the dying. Differentiate between the programs. What are the benefits of each one for the family of the dying? How do they address different cultures? How might cultural differences impact the experience of a caregiver? 

 

Read Chapters 6, 7, 8, and 20 in Death & Dying, Life & Living.

 

Corr, C. A., Corr, D. M., & Doka, K. J. (2019). Death & dying, life & living. Boston, MA: Cengage.

How do two research conclusions play off each other?” An example (not using 600 materials to avoid limiting your creativity!):

/in /by

November 24th: Response paper: Choose one of the topics presented below. 1. Please write on your first page “ Topic 1,” “Topic 2,” “Topic 3,” or “Topic 4.” 2. The length of the paper should be 4-5 pages (maximum 1,250 words). 3. You must use at least 2 academic articles from the syllabus and a third source may come from an additional article, a lecture, or one of the videos from the syllabus. You cannot use the Doidge book as one of the academic articles but it may be used in addition.

 

TOPIC 1: Write about how positive psychology can further advance a field of interest (such as healthcare) or a need in society (such as nourishing our green environment) or a need in the world (such as positive peacekeeping in the middle east). A shortcut to this topic is, “Considering positive psychology’s aim to enhance human flourishing worldwide, how can the field make a significant impact on promoting healthy environments and institutions?” We want you to think big and dream, using empirically- based constructs of positive psychology to support your vision. An example: “’Green’ is a buzzword. Individuals, homes, businesses and communities are working to support environmentally friendly living. Positive psychology can help” (And then describe the ways in which PERMA, and/or self-regulation, and/or goal-setting, etc can support this effort). Have fun. PS. Write about how positive psychology can advance the career you are advancing. Since we have covered how positive psychology is advancing the field of education in the work of Dweck and the KIPP schools, if you are going to discuss education please do not focus on their achievements.

 

TOPIC 2: Write about how two specific research conclusions (from the readings, lectures, or the in-class guests) inter-relate, complement, or contradict each other. Here you have the chance to dig into the details of these research theories and offer you own analytical commentary. A shortcut to this topic is, “How do two research conclusions play off each other?” An example (not using 600 materials to avoid limiting your creativity!): “ Goal-Setting Theory and Hope Theory are not only complements to each other, but ineffective without each other.” Have fun.

 

TOPIC 3: Create a unique, comprehensive model organizing the ideas of positive psychology. We are not asking you to restate the five areas we covered or to regurgitate things you have read, but to consider a different model for how positive psychology concepts go together and interact. What do you think should be at the heart of positive psychology – is it the notion of flourishing, or something else? Can you think of a new way to unify the components of positive psychology in a novel theoretical framework? A drawing or figure is very welcome. Make this something that you’re proud of. Have fun.

List possible risks associated with not taking this agent for the disorder, disease, or condition:

/in /by

University of Phoenix Material

 

Neurotransmitter Chart

 

Select four neurotransmitters. Complete a table for each neurotransmitter.

 

Neurotransmitter 1 State if this neurotransmitter is inhibitory or excitatory:
(INSERT NAME OF NEUROTRANSMITTER HERE)
What is this neurotransmitter’s role on behavior?
Pharmacological agent prescribed to increasethe neurotransmitter: List three possible side effects linked to this agent:
1)
2)
3)
Example of a neurological disorder, disease, or condition where this agent occurs List possible risks associated with not taking this agent for the disorder, disease, or condition:
Pharmacological agent prescribed todecreasethe neurotransmitter: List three possible side effects linked to this agent:
1)
2)
3)
Example of a neurological disorder, disease, or condition where this agent occurs List possible risks associated with not taking this agent for the disorder, disease, or condition:

 

Neurotransmitter 2 State if this neurotransmitter is inhibitory or excitatory:
(INSERT NAME OF NEUROTRANSMITTER HERE)
What is this neurotransmitter’s role on behavior?
Pharmacological agent prescribed to increasethe neurotransmitter: List three possible side effects linked to this agent:
1)
2)
3)
Example of a neurological disorder, disease, or condition where this agent occurs List possible risks associated with not taking this agent for the disorder, disease, or condition:
Pharmacological agent prescribed todecreasethe neurotransmitter: List three possible side effects linked to this agent:
1)
2)
3)
Example of a neurological disorder, disease, or condition where this agent occurs List possible risks associated with not taking this agent for the disorder, disease, or condition:

 

Neurotransmitter 3 State if this neurotransmitter is inhibitory or excitatory:
(INSERT NAME OF NEUROTRANSMITTER HERE)
What is this neurotransmitter’s role on behavior?
Pharmacological agent prescribed to increasethe neurotransmitter: List three possible side effects linked to this agent:
1)
2)
3)
Example of a neurological disorder, disease, or condition where this agent occurs List possible risks associated with not taking this agent for the disorder, disease, or condition:
Pharmacological agent prescribed todecreasethe neurotransmitter: List three possible side effects linked to this agent:
1)
2)
3)
Example of a neurological disorder, disease, or condition where this agent occurs List possible risks associated with not taking this agent for the disorder, disease, or condition:

 

Neurotransmitter 4 State if this neurotransmitter is inhibitory or excitatory:
(INSERT NAME OF NEUROTRANSMITTER HERE)
What is this neurotransmitter’s role on behavior?
Pharmacological agent prescribed to increasethe neurotransmitter: List three possible side effects linked to this agent:
1)
2)
3)
Example of a neurological disorder, disease, or condition where this agent occurs List possible risks associated with not taking this agent for the disorder, disease, or condition:
Pharmacological agent prescribed todecreasethe neurotransmitter: List three possible side effects linked to this agent:
1)
2)
3)
Example of a neurological disorder, disease, or condition where this agent occurs List possible risks associated with not taking this agent for the disorder, disease, or condition:

Describe the quality of your working relationship with your colleague. ( The Quality of the working relationships went really well, very easy going, open-minded and productive collaborate teamwork working with my colleagues so far)

/in /by

Collaboration is a key part of social work practice. Most MSW professionals engage in these processes during the postgraduate practice years that each state requires before their licensing moves from supervised to independent status. Even beyond those requirements, peer consultation and collaboration are key aspects of most social work practice settings.

For this Assignment, your Instructor has paired you with a consultation colleague. Imagine that you and your colleague are working with the client featured in the case study your Instructor assigned. Your task is to provide a diagnosis and present your findings in the Week 7 Discussion.

Your diagnosis can come from any part of the DSM-5, so frequent communication and research with your colleague may be needed. Your colleague is there to help you think out, consult on, challenge, research, and polish your process before you record and post your own final analysis of this case in Week 7.

The collaboration that begins in this Assignment is intended to provide a safe venue for developing your differential diagnosis and case discussion skills with your colleague. This week you meet with your assigned partner at least once via Collaborate Ultra and begin considering the assigned case. In this Assignment, you describe that meeting and any initial analysis of the case.

To prepare:

  • Using the case study provided to you by your instructor.
  • Consult the Case Collaboration Meeting Guidelines document found in the Learning Resources.
  • Read ahead to the Week 7 Discussion instructions so that you can plan and reflect accordingly.

Note: In the Week 7 Discussion, you make your final findings presentation as an individual, not with your partner.

By Day 7

Submit a 1- to 2-page paper in which you describe your team meeting. In your write-up, make sure to address the following:

  • Describe the quality of your working relationship with your colleague. ( The Quality of the working relationships went really well, very easy going, open-minded and productive collaborate teamwork working with my colleagues so far)
    • Critically reflect on strengths of collaborative relationship and areas for improvement.
  • Describe your case in 100–150 words
  • Identify the red flags in your case study to be further evaluated. ( Red flags were Alcohol, suicidal thoughts, abuse, overdose, family history, cannot keep a job longer than 3 years, and attempted suicide. )
  • Outline your and your partner’s plan for further research and consultation, identifying specific tasks that you are each doing in this regard. ( I will be researching and working on the possibility of a diagnosis of Bipolar 2 and studying The case of Sigmund more thoroughly. Toni will be working on and researching BIpolar 1 and Somang will be working on possible other diagnoses such as major depression and attachment disorders. )
  • Identify days/times you have agreed to meet together, including the date planned to complete the CFI interview required for the Week 5 Assignment. We have agreed and decided to meet again via ultra collaborative or via email with our findings and research by Monday at 9 am September 23rd. IF that does not work due to one being out of town collaboration will be via email.